176 related articles for article (PubMed ID: 25821337)
1. α-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus.
Aitken JP; Ortiz C; Morales-Bozo I; Rojas-Alcayaga G; Baeza M; Beltran C; Escobar A
Dis Markers; 2015; 2015():128653. PubMed ID: 25821337
[TBL] [Abstract][Full Text] [Related]
2. Association of salivary alpha 2-macroglobulin levels and clinical characteristics in type 2 diabetes.
Chung TJ; Hsu KY; Chen JH; Liu JS; Chang HW; Li PF; Huang CL; Shieh YS; Lee CH
J Diabetes Investig; 2016 Mar; 7(2):190-6. PubMed ID: 27042270
[TBL] [Abstract][Full Text] [Related]
3. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Salivary Alpha-2 Macroglobulin and HbA1c among Patients with Type-2 Diabetes Mellitus: A Cross-sectional Study.
Rastogi V; Kalra P; Gowda MV
Indian J Endocrinol Metab; 2019; 23(2):184-187. PubMed ID: 31161100
[TBL] [Abstract][Full Text] [Related]
5. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
[TBL] [Abstract][Full Text] [Related]
6. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
[No Abstract] [Full Text] [Related]
7. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
8. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
[TBL] [Abstract][Full Text] [Related]
9. Salivary interleukin-17 and tumor necrosis factor-α in relation to periodontitis and glycemic status in type 2 diabetes mellitus.
Gürsoy UK; Yildiz Çiftlikli S; Könönen E; Gürsoy M; Doğan B
J Diabetes; 2015 Sep; 7(5):681-8. PubMed ID: 25327309
[TBL] [Abstract][Full Text] [Related]
10. Tumor Necrosis Factor-α, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects.
Kuehl MN; Rodriguez H; Burkhardt BR; Alman AC
PLoS One; 2015; 10(4):e0125320. PubMed ID: 25915398
[TBL] [Abstract][Full Text] [Related]
11. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
12. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
Sun J; Dou JT; Wang XL; Yang GQ; Lü ZH; Zheng H; Ma FL; Lu JM; Mu YM
Chin Med J (Engl); 2011 Nov; 124(22):3641-5. PubMed ID: 22340217
[TBL] [Abstract][Full Text] [Related]
13. Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes?
Hwang JS; Kim SJ; Bamne AB; Na YG; Kim TK
Clin Orthop Relat Res; 2015 May; 473(5):1726-31. PubMed ID: 25404402
[TBL] [Abstract][Full Text] [Related]
14. Validation of a hemoglobin A1c model in patients with type 1 and type 2 diabetes and its use to go beyond the averaged relationship of hemoglobin A1c and mean glucose level.
Ladyzynski P; Foltynski P; Bak MI; Sabalinska S; Krzymien J; Kawiak J
J Transl Med; 2014 Dec; 12():328. PubMed ID: 25491199
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between Glycemic Control and Concomitant Hypertension on Arterial Stiffness in Type II Diabetes.
Nuamchit T; Siriwittayawan D; Thitiwuthikiat P
Vasc Health Risk Manag; 2020; 16():343-352. PubMed ID: 32943869
[TBL] [Abstract][Full Text] [Related]
16. Mean platelet volume predicts the glycemic control deterioration in diabetes mellitus type 2 patients.
Kadić D; Hasić S; Spahić E
Med Glas (Zenica); 2016 Feb; 13(1):1-7. PubMed ID: 26827701
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
Kim MJ; Jung HS; Hwang-Bo Y; Cho SW; Jang HC; Kim SY; Park KS
Acta Diabetol; 2013 Aug; 50(4):505-10. PubMed ID: 21688018
[TBL] [Abstract][Full Text] [Related]
18. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
[TBL] [Abstract][Full Text] [Related]
19. The usage of fasting glucose and glycated hemoglobin for the identification of unknown type 2 diabetes in high risk patients with morbid obesity.
Valderhaug TG; Sharma A; Kravdal G; Rønningen R; Nermoen I
Scand J Clin Lab Invest; 2017 Nov; 77(7):505-512. PubMed ID: 28715238
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
